Otsuka ICU Medical outlays $500m to expand US manufacturing footprint
Otsuka ICU Medical is investing $500m into expanding its US-based IV manufacturing provision to improve long-term supply resiliency. The company,…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
FDA clears iHealthScreen’s AI diabetic retinopathy screening software
Software as a Medical Device (SaMD) developer iHealthScreen has obtained US Food and Drug Administration (FDA) clearance for iPredict-DR, an artificial…
-
GE HealthCare and Mayo Clinic partner for new theranostics research study
GE HealthCare and Mayo Clinic are establishing a new research collaboration to advance personalised approaches to radioligand therapy (RLT) for…
-
Leo Cancer Care raises $65m for upright radiotherapy platform
Leo Cancer Care has raised $65m to advance manufacturing and commercial deployment activities surrounding its upright radiotherapy platform. The company’s…
-
Resmed sharpens sleep care focus with $490m software business sale
Resmed has agreed to sell its MatrixCare business in a $490m cash deal to PE firm Frazier Healthcare Partners, allowing…
-
Ottobock expands neuro-orthotics portfolio with Fesia Technology acquisition
Ottobock has agreed to acquire Spanish medical device company Fesia Technology in a strategic move to expand its neuro-orthotics portfolio…
-
Beckman Coulter’s Alzheimer’s blood test obtains CE mark
Beckman Coulter Diagnostics has secured a CE mark for a blood test to aid in the clinical evaluation of amyloid…
-
Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight
Alcon and RxSight are pairing up to jointly develop a new adjustable lens to give surgeons the ability to fine-tune…
-
Natera demonstrates MRD test benefit in colorectal cancer patients
New data from Natera has demonstrated its Signatera molecular residual disease (MRD) test’s role in determining which resected colorectal liver…
-
AdaptHealth discloses June cyberattack resulting in patient data exposure
AdaptHealth has revealed it was hit by a cyberattack resulting in data exfiltration last month, yet stressed that vital customer…